Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherap (Q42705798)
Jump to navigation
Jump to search
scientific article published on 13 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherap |
scientific article published on 13 May 2014 |
Statements
1 reference
Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherap (English)
1 reference
Cheng Hua Jin
1 reference
Maddeboina Krishnaiah
1 reference
Domalapally Sreenu
1 reference
Vura B Subrahmanyam
1 reference
Kota S Rao
1 reference
Hwa Jeong Lee
1 reference
So-Jung Park
1 reference
Hyun-Ju Park
1 reference
Kiho Lee
1 reference
Yhun Yhong Sheen
1 reference
Dae-Kee Kim
1 reference
13 May 2014
1 reference
1 reference
Identifiers
1 reference